Abstract
Transport®NPC: open phase 3 global trial of intravenous hydroxy-propyl-beta-cyclodextrin in patients with Niemann-Pick disease type C1 (NPC1)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have